ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Patient centricity in insulin injection: Using technology to improve self-administration
David T. Novotny considers the current and future developments in injection technology.
Putting patients at the heart of clinical trials
Scott Palmese, Senior Director, Accellacare Site Network, shares his insights on optimising the patient experience within clinical trials, and the ramifications of the COVID-19 pandemic.
Embedded blended solutions - A new way to optimise clinical trial portfolio delivery
John Barry and Brian Swindley offer their insights on the options available to pharma companies when delivering their clinical trial portfolios.
Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity
Emily Mitchell discusses the importance of considering the target patient population when designing and deploying a decentralised clinical trial.
Triangle's CRO industry saw a flurry of M&A activity over past year
This article provides an overview of the mergers and acquisition activity across 2021 that have involved CROs based or heavily present in the North Carolina Triangle, which includes ICON’s $12bn acquisition of PRA Health Sciences.
Using cross-functional teams to develop a product's value story
Experts from the Commercial Solutions team discuss how essential a data-driven strategy is to successfully communicate a brand’s value proposition in a competitive market.
ICON plc (ICLR) Q4 earnings meet estimates
This article summarises ICON’s quarterly and 2021 year-end financial results.
So what sectors had the most M&A activity?
This article shares how the medical and biotech sectors have dominated the mergers & acquisitions (M&A) landscape and mentions ICON’s acquisition of PRA Health Sciences.
A ‘banner year’ for M&A activity across Ireland
This article provides an overview of the mergers and acquisition activity that took place in Ireland across 2021. This includes ICON’s $12bn acquisition of PRA Health Sciences as one of the “big deals of 2021”.
Two-part series: The evolution of data technology
In this two-part series, Emily Mitchell and Kathleen Mandziuk offer their insights on the evolution of data technology.